Publish Your Protocol in Exploration of Targeted Anti-tumor Therapy
Advancing in Translational Cancer Research Through Shared Innovation
Scope & Template
Translational cancer research requires the use of increasingly sophisticated technologies for the analysis of prognostic and predictive biomarkers. Validation of new technologies is a long and expensive process that laboratories working in this field of research must face.
ETAT offers the possibility to publish protocols and validation data of new technologies in a dedicated section, to promote the dissemination of new technologies that improve the quality level of translational cancer research.
Download structured templates for Protocol.
Why Submit Your Protocol Here?
✅ Limited-Time APC Waiver: 100% fee waiver for protocols submitted before December 31, 2025.
✅ Global Visibility: Indexed in PMC/PubMed, Scopus, and Google Scholar, maximizing the exposure, readership, and citation of the articles.
✅ Open Access with Author Rights: Retain full copyright while your work reaches wider audiences through barrier-free access.
✅ Annual "Highly Cited Paper Award: Award 300-1,000 USD for articles cited 5+ times within a year.